n-methyl-3,4-methylenedioxyamphetamine has been researched along with Absence Status in 2 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years." | 7.77 | Amphetamine-associated seizures: clinical features and prognosis. ( Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J, 2011) |
"Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years." | 3.77 | Amphetamine-associated seizures: clinical features and prognosis. ( Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JW | 1 |
Dunne, JW | 1 |
Fatovich, DM | 1 |
Fatovic, DM | 1 |
Lee, J | 1 |
Lawn, ND | 1 |
Hall, AP | 1 |
Lyburn, ID | 1 |
Spears, FD | 1 |
Riley, B | 1 |
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Absence Status
Article | Year |
---|---|
Amphetamine-associated seizures: clinical features and prognosis.
Topics: Adolescent; Adult; Amphetamine; Anticonvulsants; Central Nervous System Stimulants; Electroencephalo | 2011 |
An unusual case of Ecstasy poisoning.
Topics: Adult; Creatine Kinase; Dantrolene; Humans; Male; Muscle Relaxants, Central; N-Methyl-3,4-methylened | 1996 |